Zimmer Biomet’s ZimVie Picks up SteamZimmer Biomet’s ZimVie Picks up Steam

The Warsaw, IN-based company has filed a form 10 registration statement in connection with ZimVie.

Omar Ford

January 24, 2022

1 Min Read
IMG_2022-1-24-154512.jpg
ZUMA Press, Inc. / Alamy Stock Photo

Zimmer Biomet has filed a Form 10 statement to move forward with ZimVie, its dental and spine business spinoff. The company first announced the spinoff in February of 2021.

Next month, ZimVie will host a virtual Investor Day on Monday, Feb. 7, 2022 from 11 a.m. to about 3p.m. E.T. The virtual event will feature presentations from ZimVie leaders outlining its Dental and Spine offerings, addressable market opportunity, financial outlook, business strategy, and the broader organizations supporting these businesses.

ZimVie is the result of the third phase of Zimmer Biomet’s transformation. Prior to the announced spin-off Zimmer Biomet struggled with quality control and supply chain problems for about a year at that point, and those challenges had created investor frustration that ultimately led to former CEO David Dvorak's resignation in July 2017.

Bryan Hanson took the helm in December of 2017 and in October 2018, he  told investors that Zimmer Biomet would have to reduce the size of its portfolio in order to simplify the supply chain and improve service levels to customers. 

Vfa Jamali, a former Medtronic executive will serve as CEO of ZimVie.

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like